Clinical Trial Update: International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa [Phase 3]

View source ↗

Summary

Phase 3 trial update for aztreonam for inhalation solution (Cayston) evaluating safety and efficacy in cystic fibrosis patients with Pseudomonas aeruginosa; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Cayston (aztreonam lysine)

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2011-04-21